From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

GOTCHA! Technology Minerals – why interims and year accounts need to be restated to consolidate Recyclus Group, shares must be suspended NOW

By Tom Winnifrith | Wednesday 27 March 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Technology Minerals (TM1) published its interim results for the six months ended 31 December 2023 today which showed a loss of £1,476,000 and net assets of £20,639,000. They are erroneous and need to be restated as do last year's finals and that throws its plans to get the FCA to approve an RTO prospectus into disarray. I shall be reporting Technology to the FCA and FRC today. So here is why this company co-founded by disgraced Chris Cleverly has breached the rules and why its shares should be suspended which, given its reliance on death spiral funding, could well trigger bankruptcy...
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 21:54:29